CLINICAL EVIDENCE • PATIENT SELECTION • IMPLANT PRACTICE
CHAIRS
BRADLEY P. KNIGHT, MD • LARRY A. CHINITZ, MD • THOMAS F. DEERING, MD
MICHAEL R. GOLD, MD, PHD
The role of autonomic modulation for the treatment of heart failure and the BAROSTIM NEO system mechanism of action.
MARWAN M. BAHU, MD FHRS
BAROSTIM NEO Device Implantation Experience
KHALED A. AWAD, MD, MUSC
Heart failure device treatment algorithm and BAROSTIM NEO patient selection
LUANDA GRAZETTE, MD, MPH
Barostim Therapy Clinical Evidence